T46.2X4
Poisoning by other antidysrhythmic drugs, undetermined
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by other antidysrhythmic drugs, undetermined, is a medical condition that occurs when an individual is exposed to certain heart rhythm-controlling medications in a harmful or toxic manner. Antidysrhythmic drugs are used to help regulate irregular heartbeats, but excessive or improper use can lead to poisoning. This condition can result from accidental overdose, misuse, or adverse reactions. It is categorized under the ICD-10 code T46.2X4, which helps healthcare providers classify and manage cases effectively.
Causes & Symptoms
Clinical Causes: Accidental overdose of antidysrhythmic medications Intentional misuse or abuse of these drugs Incorrect medication dosage or administration Drug interactions leading to toxicity Unintentional ingestion, especially in children or vulnerable populations Adverse reactions due to other underlying health conditions
Key Symptoms: Dizziness or lightheadedness Nausea and vomiting Blurred vision or visual disturbances Confusion or altered mental state Slow or irregular heartbeats (bradycardia or arrhythmias) Shortness of breath or difficulty breathing Weakness or fatigue Fainting or loss of consciousness Seizures in severe cases Chest pain or discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically begins with a thorough medical history review and physical examination. Healthcare providers may perform various tests, including:
Treatment Protocols: Treatment strategies focus on managing symptoms, preventing complications, and removing toxic substances from the body. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T46.2X4 a billable ICD-10 code?
Yes, T46.2X4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.2X4?
Clinical documentation must specify the nature of Poisoning by other antidysrhythmic drugs, undetermined and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
